Appointment booking for Dr. April Kennedy, MD is currently not available.Dr. April Kennedy, MD has not yet fully activated their profile on DiabetesIQ.
Dr. April Kennedy, MD (she/her) is a Nephrologist in Chicago, IL with over 18 years of experience. What is your opinion of Dr. April Kennedy, MD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. April Kennedy, MD has received over $1,572 which includes payments from the following companies:
$312.34 from Fresenius USA Marketing, Inc.
$239.74 from OPKO Pharmaceuticals, LLC
$162.65 from Amgen Inc.
$155.65 from Otsuka America Pharmaceutical, Inc.
$149.92 from Mallinckrodt LLC
$128.66 from AstraZeneca Pharmaceuticals LP
$112.24 from Keryx Biopharmaceuticals, Inc.
$86.47 from sanofi-aventis U.S. LLC
$32.99 from Novartis Pharmaceuticals Corporation
$29.38 from Baxter Healthcare
$27.67 from AMAG Pharmaceuticals, Inc.
$27.02 from Questcor Pharmaceuticals
$26.08 from Mallinckrodt Enterprises LLC
$24.63 from GlaxoSmithKline, LLC.
$23.63 from Boehringer Ingelheim Pharmaceuticals, Inc.
$22.56 from AKEBIA THERAPEUTICS INC
$10.44 from Merck Sharp & Dohme Corporation
Payments received by Dr. April Kennedy, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!